Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Further to my TNSH listing idea

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Sep 21, 2021 2:10pm

86 Views

Post# 33893042

RE:RE:RE:RE:RE:Further to my TNSH listing idea

There has not been any real trading in the Convert,So the vast majority of Holders (allmost all) have a cost base equal to the face value (par) Chances of the Convert going into default appear to be very slim at the moment and will be considered as nil if there were a Tender Offer,So the Holders are getting a nice interest of over5% and a remote chance to make more if the SP exceeds the Conversion Price .... So there would be no incentive imo to tender

SPCEO1 wrote: Why wouldn't they if it gives them a nice little profit from where the convert is currently trading. There is nothing special about TH's convert - it can be easily replaced with others in any convertible portfolio. Now, I would not expect all the convert holders to convert since many are likely held in none institutional hands. But for those that are held in institutional hands they may well take you up on the offer.

palinc2000 wrote: Why would holders of the Convert tender ?? A tender Offer at par would be ignored by the Holders

SPCEO1 wrote: That is correct. But what I am talking about is a tender offer for those converts.

palinc2000 wrote: I am pretty sure that the Convert cannot be redeemed before maturity except if the SP close to maturity exceeds or is equal to the Conversion price